Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T21:58:54.181Z Has data issue: false hasContentIssue false

Trends in inpatient antibiotic use in Indonesia and the Philippines during the COVID-19 pandemic

Published online by Cambridge University Press:  25 June 2025

Amara Z. Fazal*
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
Olivia L. McGovern
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
Garrett W. Mahon
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
Fernanda C. Lessa
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
Maria Tarcela Gler
Affiliation:
Makati Medical Center, Manila, Philippines
Jemelyn Garcia
Affiliation:
Asian Hospital and Medical Center, Manila, Philippines
Mark John Festin
Affiliation:
Philippine General Hospital, University of the Philippines, Manila, Philippines
Kuntaman Kuntaman
Affiliation:
Department of Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, IndonesiaFaculty of Medicine, Airlangga University, Surabaya, Indonesia
Ida Parwati
Affiliation:
Department of Clinical Pathology, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
Cherry Siregar
Affiliation:
Adam Malik Hospital, Medan, Indonesia
Jay Christian D. Muere
Affiliation:
Makati Medical Center, Manila, Philippines
Gina De Guzman Betito
Affiliation:
Makati Medical Center, Manila, Philippines
Maya Montemayor
Affiliation:
Asian Hospital and Medical Center, Manila, Philippines
Arleen De Leon
Affiliation:
Asian Hospital and Medical Center, Manila, Philippines
Emmeline Borillo
Affiliation:
Philippine General Hospital, University of the Philippines, Manila, Philippines
Mark Ramon Victor Llanes
Affiliation:
Philippine General Hospital, University of the Philippines, Manila, Philippines
Regina Berba
Affiliation:
Philippine General Hospital, University of the Philippines, Manila, Philippines
Musofa Rusli
Affiliation:
Department of Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Mariyatul Qibtiyah
Affiliation:
Department of Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Bambang Pujo Semedi
Affiliation:
Department of Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, IndonesiaFaculty of Medicine, Airlangga University, Surabaya, Indonesia
Rosantia Sarassari
Affiliation:
Department of Clinical Microbiology, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia
Leonardus Widyatmoko
Affiliation:
Department of Clinical Pathology, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
Basti Andriyoko
Affiliation:
Department of Clinical Pathology, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
Adhi Kristianto Sugianli MD
Affiliation:
Department of Clinical Pathology, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
Dewi Kartika Turbawaty
Affiliation:
Department of Clinical Pathology, Hasan Sadikin General Hospital, Faculty of Medicine, Padjadjaran University, Bandung, Indonesia
Ivo Dhanitri Ranita
Affiliation:
Adam Malik Hospital, Medan, Indonesia
Franciscus Ginting
Affiliation:
Adam Malik Hospital, Medan, Indonesia
Rahmadania Marita Joesoef
Affiliation:
Ejikman Institute for Molecular Biology, Jakarta, Indonesia
Made Ananda Krisna
Affiliation:
Ejikman Institute for Molecular Biology, Jakarta, IndonesiaBiology Department and Nuffield Department of Clinical Medicine, University of Oxford, Oxford, England
Twisha S. Patel
Affiliation:
Centers for Disease Control and Prevention, Atlanta, GA, USA
*
Corresponding author: Amara Z. Fazal; Email: osa7@cdc.gov

Abstract

Objective:

Increased antibiotic use (AU) has been reported globally during the COVID-19 pandemic despite low rates of bacterial co-infection. We assessed changes in AU during the COVID-19 pandemic in Indonesia and the Philippines.

Methods:

We evaluated hospital-wide AU over 36 months in six hospitals, 3 in Indonesia and 3 in the Philippines. Intravenous antibiotics commonly used for respiratory conditions were selected and grouped for analysis. AU rates were calculated as monthly defined daily dose per 1000 patient-days or patient discharges. Median AU rates were compared from the pre-pandemic (March 2018–February 2020) and pandemic periods (March 2020–February 2021) using quantile regression to assess for statistical significance. Changes in AU during the COVID-19 pandemic were analyzed using interrupted time series analysis.

Results:

Significant increases were noted in the median AU rate from the pre-pandemic to pandemic period of all antibiotics combined in 3/6 hospitals (percentage change, Δ, 12.5%–63.6%) and anti-pseudomonal antibiotics in 3/6 hospitals (Δ 51.5%–161.5%). In the interrupted time series analysis, an immediate increase (range: 125.40–1762) in the use of all included antibiotics combined was observed in 3/6 hospitals at the onset of the COVID-19 pandemic. One of these 3 hospitals experienced a statistically significant sustained increase, while another experienced a decrease over time.

Conclusions:

We observed significant increases in facility-wide inpatient AU during the COVID-19 pandemic in our participating hospitals in Indonesia and the Philippines. These findings reinforce the importance of antibiotic stewardship practices to optimize AU, especially during infectious disease pandemics.

Information

Type
Original Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is a work of the US Government and is not subject to copyright protection within the United States. To the extent this work is subject to copyright outside of the United States, such copyright shall be assigned to the The Society for Healthcare Epidemiology of America and licenced to the Publisher. Outside of the United States, the. US Government retains a paid-up, non-exclusive, irrevocable worldwide license to reproduce, prepare derivative works, distribute copies to the public and display publicly the Contribution, and to permit others to do so. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America.
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Society for Healthcare Epidemiology of America (SHEA) 2025.
Figure 0

Table 1.Facility characteristics and reported changes during COVID-19 pandemic among hospitals in Indonesia and the Philippines (March 2020–February 2021)

Figure 1

Table 2.Median inpatient antibiotic use (DDD per 1000 patient days or discharges) among all included hospital wards in Indonesia (Hospitals A, B, C) and the Philippines (Hospitals D, E, F), March 2018–February 2021

Figure 2

Figure 1.Intravenous antibiotic use (AU) and COVID-19 patient discharges in hospitals over time, March 2018–February 2021.

Figure 3

Table 3.Parameter estimates from interrupted time series analysis of antibiotic use among hospitals in Indonesia (A, B, C) and the Philippines (D, E, F), March 2018–February 2021

Supplementary material: File

Fazal et al. supplementary material

Fazal et al. supplementary material
Download Fazal et al. supplementary material(File)
File 70.1 KB